Several metrics are used to measure the efficacy of cancer treatments:
Overall Survival (OS): The length of time from the start of treatment that patients are still alive. Progression-Free Survival (PFS): The length of time during and after treatment that a patient lives without the cancer worsening. Objective Response Rate (ORR): The proportion of patients with a significant reduction in tumor size. Quality of Life (QoL): Assessed through patient-reported outcomes to determine the impact of the treatment on overall well-being.
